Cp-673451
| Title | Journal |
|---|---|
| Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy. | Clinical & experimental metastasis 20080101 |
| Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. | Cancer research 20050201 |